Skip to main content

Table 4 Adjusted HRs for overall survival stratified by LC and LWR changes in cohort 2 (N = 106)

From: Lymphocyte count or percentage: which can better predict the prognosis of advanced cancer patients following palliative care?

Clinicopathological features LC Model LWR Model
Adjusted HR(95% CI) P value Adjusted HR (95% CI) P value
Gender (female vs. male) 0.859(0.496 ~ 1.486) 0.586 0.847(0.492 ~ 1.460) 0.551
Age 1.006(0.985 ~ 1.028) 0.565 0.999(0.979 ~ 1.020) 0.921
Primary tumor site 0.787(0.618 ~ 1.003) 0.053 0.751(0.590 ~ 0.955) 0.019
Tumor stage (IV vs. III) 2.813(1.076 ~ 7.356) 0.035 1.971(0.738 ~ 5.263) 0.176
Family history (Yes vs. No) 1.405(0.846 ~ 2.333) 0.189 1.424 (0.862 ~ 2.351) 0.167
Smoke history (Yes vs. No) 0.897(0.491 ~ 1.639) 0.724 0.716(0.390 ~ 1.314) 0.280
Nutrient (Abnormal vs. Normal) 0.987(0.591 ~ 1.649) 0.961 0.983(0.597 ~ 1.617) 0.945
ECOG 1.614(1.140 ~ 2.283) 0.007 1.850(1.291 ~ 2.650) 0.001
Concomitant disease (Yes vs. No) 1.165(0.714 ~ 1.899) 0.542 1.278(0.785 ~ 2.082) 0.324
LC (Increased vs. Decreased) 0.673(0.419 ~ 1.081) 0.101 -- --
LWR(Increased vs. Decreased) -- -- 0.396(0.243 ~ 0.668) 0.001
  1. LC lymphocyte count, LWR lymphocyte to white blood cell ratio, HR hazard ratio, CI confidence interval